| 1 |
35410356 | Adenosine inhibits TNFα-induced MMP-3 production in MH7A rheumatoid arthritis synoviocytes via A2A receptor signaling. | 2022 Apr 11 |
2 |
| 2 |
33185166 | Predictors of Cardiovascular Affection in Patients with Active Rheumatoid Arthritis: Secondary Analysis of a Randomized Controlled Trial. | 2021 |
1 |
| 3 |
33136246 | Alterations in the matrix metalloproteinase-3 promoter methylation after common chemotherapeutics: in vitro study of paclitaxel, cisplatin and methotrexate in the MCF-7 and SH-SY5Y cell lines. | 2020 Nov |
2 |
| 4 |
26922083 | MMP-3 as a predictor for structural remission in RA patients treated with MTX monotherapy. | 2016 Feb 27 |
2 |
| 5 |
30641006 | [Efficacy of Hebi Formula Combined Methotrexate on Early Rheumatoid Arthritis Patients with Dis- harmony of Gan and Pi Syndrome and Its Effects on Serum MMP-3 and RANK/RANKL/OPG Expressions]. | 2016 Oct |
1 |
| 6 |
26273599 | Inhibitory Effect of a Novel Antirheumatic Drug T-614 on the IL-6-Induced RANKL/OPG, IL-17, and MMP-3 Expression in Synovial Fibroblasts from Rheumatoid Arthritis Patients. | 2015 |
1 |
| 7 |
27089651 | [MMP-3 as a Biomarker of Disease Activity of Rheumatoid Arthritis]. | 2015 Dec |
2 |
| 8 |
20039425 | Rapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone. | 2010 Jan |
1 |
| 9 |
20822542 | The effect of infliximab plus methotrexate on the modulation of inflammatory disease markers in juvenile idiopathic arthritis: analyses from a randomized, placebo-controlled trial. | 2010 Sep 7 |
2 |
| 10 |
17552048 | Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis. | 2007 Jul |
3 |
| 11 |
17907159 | Biomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers. | 2007 Oct |
4 |
| 12 |
16881109 | Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis. | 2006 Aug |
1 |
| 13 |
15476228 | Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate. | 2004 Oct |
1 |
| 14 |
12022344 | Serum matrix metalloproteinase 3 levels during treatment with sulfasalazine or combination of methotrexate and sulfasalazine in patients with early rheumatoid arthritis. | 2002 May |
6 |
| 15 |
12510357 | [Usefulness of serum matrix metalloproteinase-3(MMP-3) level in the diagnosis of rheumatoid arthritis]. | 2002 Dec |
1 |